Oral clonidine reduces postoperative PCA morphine requirements

Area of Science:

• Anesthesiology
• Pharmacology
• Orthopedic Surgery

Background:

• Postoperative pain management and nausea/vomiting are significant challenges after major orthopedic surgery.
• Patient-controlled analgesia (PCA) with morphine is common but associated with side effects.
• Exploring adjuncts to multimodal analgesia is crucial for improving patient outcomes.

Purpose of the Study:

• To assess the efficacy of perioperative oral clonidine in reducing postoperative pain and morphine consumption.
• To evaluate the impact of clonidine on patient-controlled analgesia (PCA) morphine requirements.
• To determine the effect of clonidine on postoperative nausea and vomiting (NVP) after knee surgery.

Main Methods:

• Prospective, double-blind, placebo-controlled trial involving 44 adult patients undergoing knee replacement or hemiarthroplasty.
• Patients received either oral clonidine (5 µg/kg) or placebo preoperatively and postoperatively.
• Standardized anesthesia and postoperative monitoring of pain, sedation, vital signs, and PCA morphine use for 36 hours.

Main Results:

• Clonidine group used 37% less cumulative PCA morphine (57.3 mg vs. 91 mg, P=0.031).
• Significantly lower incidence of postoperative nausea (25% vs. 74%, P<0.01) and vomiting (10% vs. 53%, P<0.01) in the clonidine group.
• Clonidine was associated with preoperative sedation and lower mean arterial blood pressure, but no difference in postoperative pain or sedation scores.

Conclusions:

• Perioperative oral clonidine effectively reduces morphine requirements in the context of postoperative balanced analgesia.
• Clonidine is beneficial in decreasing the incidence of postoperative nausea and vomiting following major orthopedic knee surgery.
• Oral clonidine represents a valuable addition to multimodal analgesic strategies for orthopedic procedures.